Improved recombinant antibody production by CHO cells using a production enhancer DNA element with repeated transgene integration at a predetermined chromosomal site-Reference-Cited by-同舟云学术

Improved recombinant antibody production by CHO cells using a production enhancer DNA element with repeated transgene integration at a predetermined chromosomal site

Published:2017-03 Issue:3 Volume:123 Page:390-397
ISSN:1389-1723
Container-title:Journal of Bioscience and Bioengineering
language:en
Short-container-title:Journal of Bioscience and Bioengineering

Author:

Kawabe Yoshinori,Inao Takanori,Komatsu Shodai,Huang Guan,Ito Akira,Omasa Takeshi,Kamihira Masamichi

Funder

Ministry of Economy, Trade and Industry, Japan (METI)

Japan Agency for Medical Research and Development (AMED)

Publisher

Elsevier BV

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Reference18 articles.

1. Biopharmaceutical benchmarks 2014;Walsh;Nat. Biotechnol.,2014

2. Manufacturing recombinant proteins in kg-ton quantities using animal cells in bioreactors;De Jesus;Eur. J. Pharm. Biopharm.,2011

3. The art of CHO cell engineering: a comprehensive retrospect and future perspectives;Fischer;Biotechnol. Adv.,2015

4. 25 years of recombinant proteins from reactor-grown cells – where do we go from here?;Hacker;Biotechnol. Adv.,2009

5. Repeat-induced gene silencing in mammals;Garrick;Nat. Genet.,1998

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant Antibody-Producing Stable CHOK1 Pool Stability Study;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2024-08-01

2. Identification of a New Integration Site and Study on Site-Specific Integration in CHO-K1 Cells;Pharmaceuticals;2023-12-20

3. Recombinant Human CD19 in CHO-K1 Cells: Glycosylation Patterns as a Quality Attribute of High Yield Processes;International Journal of Molecular Sciences;2023-06-30

4. Protein expression/secretion boost by a novel unique 21-mer cis-regulatory motif (Exin21) via mRNA stabilization;Molecular Therapy;2023-04

5. An innovative platform to improve asymmetric bispecific antibody assembly, purity, and expression level in stable pool and cell line development;Biochemical Engineering Journal;2022-12